About Opiant Pharmaceuticals
Opiant Pharmaceuticals is a company based in Santa Monica (United States) founded in 2005 was acquired by Indivior in November 2022. The company has 31 employees as of December 31, 2022. Opiant Pharmaceuticals offers products and services including Addiction Treatments. Opiant Pharmaceuticals operates in a competitive market with competitors including Indivior, Biotie, Ethypharm, Braeburn and Amygdala Neurosciences, among others.
- Headquarter Santa Monica, United States
- Employees 31 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Indivior Plc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Opiant Pharmaceuticals
Opiant Pharmaceuticals offers a comprehensive portfolio of products and services, including Addiction Treatments.
Medications for managing substance use disorders effectively.
People of Opiant Pharmaceuticals
Unlock access to complete
Unlock access to complete
Leadership Team
75 people
Sales and Marketing
28 people
Senior Team
22 people
Clinical Team
17 people
Finance and Accounting
15 people
Operations Team
12 people
Software Development Team
12 people
Head Team
11 people
Unlock access to complete
Funding Insights of Opiant Pharmaceuticals
Investors in Opiant Pharmaceuticals
Opiant Pharmaceuticals has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Indivior, NIH and Kreos Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt is provided to growth-stage companies across multiple sectors.
|
Locked | Locked | Locked | |
|
Pontifax Venture Capital is focused on life sciences investments.
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked |
Investor details for Opiant Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Opiant Pharmaceuticals
Investment portfolio details for Opiant Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Opiant Pharmaceuticals
Detailed financials for Opiant Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Opiant Pharmaceuticals Comparisons
Peer comparison for Opiant Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Opiant Pharmaceuticals
Opiant Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indivior, Biotie, Ethypharm, Braeburn and Amygdala Neurosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for opioid addiction treatment are developed and commercialized.
|
|
| Locked | Locked | Locked |
Drugs for neurodegenerative and psychiatric disorders are developed by Biotie.
|
|
| Locked | Locked | Locked |
Therapies for pain and addiction treatment are developed.
|
|
| Locked | Locked | Locked |
Long-acting therapies for opioid addiction and chronic pain are developed.
|
|
| Locked | Locked | Locked |
Therapies for substance use disorders are developed by Amygdala Neurosciences.
|
Detailed competitors of Opiant Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Opiant Pharmaceuticals
Complete news archive for Opiant Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Opiant Pharmaceuticals
Opiant Pharmaceuticals was founded in 2005 and raised its 1st funding round 11 years after it was founded.
Opiant Pharmaceuticals is headquartered in Santa Monica, United States. It is registered at Santa Monica, California, United States.
As of Dec 31, 2022, the latest employee count at Opiant Pharmaceuticals is 31.
Opiant Pharmaceuticals was founded in 2005 and is headquartered in Santa Monica, United States. Operations focus on the pharmaceutical sector, where therapeutics for addictive and eating disorders are developed. The lead product, NARCAN Nasal Spray, is indicated for opioid overdose reversal. Additional pipeline assets target binge eating disorder and cocaine use disorder, supporting clinical advancements in behavioral health treatments.
Opiant Pharmaceuticals's top competitors include Indivior, Ethypharm and Amygdala Neurosciences.
Opiant Pharmaceuticals offers Addiction Treatments.
Opiant Pharmaceuticals has 6 investors. Key investors include Indivior, NIH, Kreos Capital, ADAPT Pharma, and BARDA.